CME
How Modulation of Apoptotic Pathways Can Fill Important Unmet Needs in LA SCCHN
Host: Jonathan D. Schoenfeld, MD, MPhil, MPH Guest: Robert L. Ferris, MD, PhD The treatment of LA SCCHN has remained largely unchanged for >2 decades and the standard of care, concurrent chemoradiotherapy (CRT) with high-dose cisplatin, i